These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19706991)

  • 1. Development and validation of a 0.5 mg dexamethasone suppression test as an initial screening test for the diagnosis of ACTH-dependent Cushing's syndrome.
    Oki Y; Hashimoto K; Hirata Y; Iwasaki Y; Nigawara T; Doi M; Sakihara S; Kageyama K; Suda T
    Endocr J; 2009; 56(7):897-904. PubMed ID: 19706991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparing overnight dexamethasone suppression test, urine free cortisol, and midnight serum cortisol for the initial diagnosis of Cushing' s syndrome].
    Tang TJ; Liu YP; Yu YR
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 44(5):764-8. PubMed ID: 24325108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
    Aron DC; Raff H; Findling JW
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1780-5. PubMed ID: 9177382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the diagnostic criteria for Cushing's disease in Japan.
    Kageyama K; Oki Y; Sakihara S; Nigawara T; Terui K; Suda T
    Endocr J; 2013; 60(2):127-35. PubMed ID: 23171704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
    Dichek HL; Nieman LK; Oldfield EH; Pass HI; Malley JD; Cutler GB
    J Clin Endocrinol Metab; 1994 Feb; 78(2):418-22. PubMed ID: 8106630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A dose-response study of salivary cortisol after dexamethasone suppression test in Cushing's disease and its potential use in the differential diagnosis of Cushing's syndrome.
    Castro M; Elias LL; Elias PC; Moreira AC
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):800-5. PubMed ID: 14974925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of non-invasive dynamic tests in the diagnosis of Cushing's syndrome.
    Vilar L; Freitas MC; Naves LA; Canadas V; Albuquerque JL; Botelho CA; Egito CS; Arruda MJ; Silva LM; Arahata CM; Agra R; Lima LH; Azevedo M; Casulari LA
    J Endocrinol Invest; 2008 Nov; 31(11):1008-13. PubMed ID: 19169058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of CRH stimulation test and overnight 8 mg dexamethasone suppression test in 469 patients with ACTH-dependent Cushing's syndrome.
    Detomas M; Ritzel K; Nasi-Kordhishti I; Wolfsberger S; Quinkler M; Losa M; Tröger V; Kroiss M; Fassnacht M; Vila G; Honegger JB; Reincke M; Deutschbein T
    Front Endocrinol (Lausanne); 2022; 13():955945. PubMed ID: 36277711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Optimized Pathway for the Differential Diagnosis of ACTH-Dependent Cushing's Syndrome Based on Low-Dose Dexamethasone Suppression Test.
    Chen K; Chen S; Lu L; Zhu H; Zhang X; Tong A; Pan H; Wang R; Lu Z
    Front Endocrinol (Lausanne); 2021; 12():720823. PubMed ID: 34539574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of cortisol and ACTH responses to the desmopressin test in patients with Cushing's syndrome and simple obesity.
    Tsagarakis S; Vasiliou V; Kokkoris P; Stavropoulos G; Thalassinos N
    Clin Endocrinol (Oxf); 1999 Oct; 51(4):473-7. PubMed ID: 10583315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overnight dexamethasone suppression test in the diagnosis of Cushing's disease.
    Esfahanian F; Kazemi R
    Acta Med Iran; 2010; 48(4):222-5. PubMed ID: 21279933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A very high dose dexamethasone suppression test for differential diagnosis of Cushing's syndrome.
    al-Saadi N; Diederich S; Oelkers W
    Clin Endocrinol (Oxf); 1998 Jan; 48(1):45-51. PubMed ID: 9509067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The corticotrophin-releasing hormone test is the most reliable noninvasive method to differentiate pituitary from ectopic ACTH secretion in Cushing's syndrome.
    Reimondo G; Paccotti P; Minetto M; Termine A; Stura G; Bergui M; Angeli A; Terzolo M
    Clin Endocrinol (Oxf); 2003 Jun; 58(6):718-24. PubMed ID: 12780748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nocturnal 8 mg dexamethasone suppression test: a practical and accurate test for identification of the cause of endogenous Cushing's syndrome.
    Sriussadaporn S; Ploybutr S; Peerapatdit T; Plengvidhya N; Nitiyanant W; Vannasaeng S; Vichayanrat A
    Br J Clin Pract; 1996; 50(1):9-13. PubMed ID: 8729595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The continuous 7-hour intravenous dexamethasone suppression test in the differential diagnosis of ACTH-dependent Cushing's syndrome.
    van den Bogaert DP; de Herder WW; de Jong FH; Biemond P; van der Lely AJ; Lamberts SW
    Clin Endocrinol (Oxf); 1999 Aug; 51(2):193-8. PubMed ID: 10468990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome.
    Isidori AM; Kaltsas GA; Mohammed S; Morris DG; Jenkins P; Chew SL; Monson JP; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5299-306. PubMed ID: 14602765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of efficacy between the serum cortisol and 24 hour urine free cortisol in combined dexamethasone suppression test in the diagnosis of Cushing syndrome].
    Lu L; Chen JH; Zhu HJ; Song AL; Li M; Chen S; Pan H; Gong FY; Wang RZ; Xing B; Yao Y; Feng M; Lu ZL
    Zhonghua Yi Xue Za Zhi; 2016 Jul; 96(27):2150-4. PubMed ID: 27464539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low Diagnostic Utility of Overnight High-Dose Dexamethasone Suppression Test in ACTH-Dependent Cushing's Syndrome.
    Kumar A; Kanwar J; Bharti N; Agrawal V; Bhatia E; Yadav SC
    Endocr Pract; 2021 Jul; 27(7):723-727. PubMed ID: 34250909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reevaluation of the combined dexamethasone suppression-corticotropin-releasing hormone test for differentiation of mild cushing's disease from pseudo-Cushing's syndrome.
    Gatta B; Chabre O; Cortet C; Martinie M; Corcuff JB; Roger P; Tabarin A
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4290-3. PubMed ID: 17635947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late-night salivary cortisol as a screening test for the diagnosis of Cushing's syndrome in Japan.
    Doi M; Sekizawa N; Tani Y; Tsuchiya K; Kouyama R; Tateno T; Izumiyama H; Yoshimoto T; Hirata Y
    Endocr J; 2008 Mar; 55(1):121-6. PubMed ID: 18202529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.